4/A

FORM 4/A SUBMISSION

Company: Tvardi Therapeutics, Inc.
Filed: November 24, 2020
Period of Report: November 19, 2020
Accession Number: 0001209191-20-060288

View Document ↗ View on SEC.gov ↗